Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO29191 | Schisandra neglecta | Species | Schisandraceae | Eukaryota | Stems | Luoji Mountain Village, Xichang County, Sicuan Province, China | 2011-SEP |
PMID[23738539] |
NPO7850 | Schisandra propinqua | Species | Schisandraceae | Eukaryota | aerial parts | Erlang Mountain area of Sichuan Province, China | 2007-SEP |
PMID[19413342] |
NPO29191 | Schisandra neglecta | Species | Schisandraceae | Eukaryota | UNPD* | |||
NPO6903 | Lecanora straminea | Species | Lecanoraceae | Eukaryota | UNPD* | |||
NPO11167 | Prunus ssiori | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO14102 | Kadsura interior | Species | Schisandraceae | Eukaryota |
PMID[12350139] |
|||
NPO27599 | Kadsura ananosma | Species | Schisandraceae | Eukaryota | Seeds |
PMID[21381710] |
||
NPO7850 | Schisandra propinqua | Species | Schisandraceae | Eukaryota | UNPD* | |||
NPO7374 | Seseli montanum | Species | Apiaceae | Eukaryota | UNPD* | |||
NPO7128 | Cynthia savignyi | NA | NA | NA | UNPD* | |||
NPO9834 | Veronica austriaca | Species | Plantaginaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | Activity | = | 16 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 59 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 78.9 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 12350139 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 60 | % | 12350139 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | = | 9900 | nM | 19413342 |
NPT2 | Others | Unspecified | Ratio CC50/EC50 | > | 20.2 | 19413342 | ||
NPT1452 | Cell Line | C8166 | Homo sapiens | CC50 | > | 200000 | nM | 19413342 |
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Activity | = | 45.7 | % | 21381710 |
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Activity | = | 53.6 | % | 21381710 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 10000 | nM | 23738539 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | > | 10000 | nM | 23738539 |
NPT2 | Others | Unspecified | IC50 | > | 10000 | nM | 23738539 | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 10000 | nM | 23738539 |
NPT2678 | Cell Line | NB-4 | Homo sapiens | IC50 | > | 10000 | nM | 23738539 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC198129 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC327352 |
1.0 | High Similarity | NPC252281 |
1.0 | High Similarity | NPC477375 |
0.9929 | High Similarity | NPC477376 |
0.9929 | High Similarity | NPC477374 |
0.9929 | High Similarity | NPC322426 |
0.9859 | High Similarity | NPC316989 |
0.9789 | High Similarity | NPC85141 |
0.9786 | High Similarity | NPC327651 |
0.9786 | High Similarity | NPC318286 |
0.9716 | High Similarity | NPC321958 |
0.9716 | High Similarity | NPC321696 |
0.9714 | High Similarity | NPC326144 |
0.9655 | High Similarity | NPC53669 |
0.9655 | High Similarity | NPC16791 |
0.9655 | High Similarity | NPC77237 |
0.9655 | High Similarity | NPC477377 |
0.9655 | High Similarity | NPC217708 |
0.9655 | High Similarity | NPC308739 |
0.9655 | High Similarity | NPC297271 |
0.9655 | High Similarity | NPC126405 |
0.9655 | High Similarity | NPC24562 |
0.9643 | High Similarity | NPC218510 |
0.9643 | High Similarity | NPC76415 |
0.9586 | High Similarity | NPC475229 |
0.9586 | High Similarity | NPC477378 |
0.9524 | High Similarity | NPC476065 |
0.9517 | High Similarity | NPC224472 |
0.9459 | High Similarity | NPC477380 |
0.9459 | High Similarity | NPC473323 |
0.9456 | High Similarity | NPC348849 |
0.9456 | High Similarity | NPC178195 |
0.9456 | High Similarity | NPC198461 |
0.9456 | High Similarity | NPC312763 |
0.9396 | High Similarity | NPC477885 |
0.9396 | High Similarity | NPC475592 |
0.932 | High Similarity | NPC471154 |
0.931 | High Similarity | NPC316676 |
0.931 | High Similarity | NPC325720 |
0.9286 | High Similarity | NPC865 |
0.9257 | High Similarity | NPC474606 |
0.9252 | High Similarity | NPC303519 |
0.9252 | High Similarity | NPC475756 |
0.9241 | High Similarity | NPC295297 |
0.9211 | High Similarity | NPC319749 |
0.9205 | High Similarity | NPC325122 |
0.9205 | High Similarity | NPC230531 |
0.9205 | High Similarity | NPC215400 |
0.9195 | High Similarity | NPC473425 |
0.9184 | High Similarity | NPC473989 |
0.9133 | High Similarity | NPC238834 |
0.9116 | High Similarity | NPC474347 |
0.9116 | High Similarity | NPC474393 |
0.9085 | High Similarity | NPC191352 |
0.9085 | High Similarity | NPC258322 |
0.9078 | High Similarity | NPC143895 |
0.9073 | High Similarity | NPC29727 |
0.9071 | High Similarity | NPC185680 |
0.9071 | High Similarity | NPC256776 |
0.9071 | High Similarity | NPC145722 |
0.9054 | High Similarity | NPC470916 |
0.9054 | High Similarity | NPC477381 |
0.9032 | High Similarity | NPC477884 |
0.9026 | High Similarity | NPC280778 |
0.9007 | High Similarity | NPC117154 |
0.9 | High Similarity | NPC474514 |
0.8993 | High Similarity | NPC477379 |
0.898 | High Similarity | NPC137352 |
0.898 | High Similarity | NPC183083 |
0.8974 | High Similarity | NPC83049 |
0.8974 | High Similarity | NPC320471 |
0.8974 | High Similarity | NPC118162 |
0.8966 | High Similarity | NPC324962 |
0.8944 | High Similarity | NPC11453 |
0.8944 | High Similarity | NPC32189 |
0.8897 | High Similarity | NPC229172 |
0.8897 | High Similarity | NPC36531 |
0.8897 | High Similarity | NPC230538 |
0.8897 | High Similarity | NPC103637 |
0.8896 | High Similarity | NPC63061 |
0.8889 | High Similarity | NPC216434 |
0.8889 | High Similarity | NPC103448 |
0.8874 | High Similarity | NPC149735 |
0.8857 | High Similarity | NPC141493 |
0.8857 | High Similarity | NPC184928 |
0.8844 | High Similarity | NPC475868 |
0.8819 | High Similarity | NPC201404 |
0.8819 | High Similarity | NPC53722 |
0.8819 | High Similarity | NPC290714 |
0.8808 | High Similarity | NPC220577 |
0.8805 | High Similarity | NPC477883 |
0.8797 | High Similarity | NPC311912 |
0.8797 | High Similarity | NPC79322 |
0.8792 | High Similarity | NPC477879 |
0.8784 | High Similarity | NPC474054 |
0.8782 | High Similarity | NPC61141 |
0.8776 | High Similarity | NPC172171 |
0.8776 | High Similarity | NPC475000 |
0.8776 | High Similarity | NPC121661 |
0.8776 | High Similarity | NPC474036 |
0.8776 | High Similarity | NPC143092 |
0.8776 | High Similarity | NPC18211 |
0.8776 | High Similarity | NPC239254 |
0.8776 | High Similarity | NPC87883 |
0.8776 | High Similarity | NPC73467 |
0.8767 | High Similarity | NPC287124 |
0.8767 | High Similarity | NPC474295 |
0.875 | High Similarity | NPC475141 |
0.8742 | High Similarity | NPC210642 |
0.8742 | High Similarity | NPC13985 |
0.8742 | High Similarity | NPC88557 |
0.8716 | High Similarity | NPC166506 |
0.8716 | High Similarity | NPC110763 |
0.8716 | High Similarity | NPC197352 |
0.8716 | High Similarity | NPC189239 |
0.8696 | High Similarity | NPC477881 |
0.8693 | High Similarity | NPC273578 |
0.8693 | High Similarity | NPC473736 |
0.8684 | High Similarity | NPC104353 |
0.8675 | High Similarity | NPC24425 |
0.8675 | High Similarity | NPC149505 |
0.8667 | High Similarity | NPC40654 |
0.8667 | High Similarity | NPC304821 |
0.8667 | High Similarity | NPC262804 |
0.8662 | High Similarity | NPC261812 |
0.8662 | High Similarity | NPC65183 |
0.8662 | High Similarity | NPC72046 |
0.8662 | High Similarity | NPC475856 |
0.8658 | High Similarity | NPC154971 |
0.8658 | High Similarity | NPC193779 |
0.8658 | High Similarity | NPC252286 |
0.8649 | High Similarity | NPC477701 |
0.8649 | High Similarity | NPC141569 |
0.8649 | High Similarity | NPC166884 |
0.8643 | High Similarity | NPC149008 |
0.8643 | High Similarity | NPC283114 |
0.8643 | High Similarity | NPC207702 |
0.8639 | High Similarity | NPC40237 |
0.8639 | High Similarity | NPC133934 |
0.8639 | High Similarity | NPC184684 |
0.8639 | High Similarity | NPC184641 |
0.8639 | High Similarity | NPC151423 |
0.8621 | High Similarity | NPC196420 |
0.8611 | High Similarity | NPC25333 |
0.8611 | High Similarity | NPC49235 |
0.8611 | High Similarity | NPC148893 |
0.8608 | High Similarity | NPC469475 |
0.8608 | High Similarity | NPC475865 |
0.8608 | High Similarity | NPC469518 |
0.8601 | High Similarity | NPC266848 |
0.8601 | High Similarity | NPC136750 |
0.8601 | High Similarity | NPC1474 |
0.8591 | High Similarity | NPC477702 |
0.8591 | High Similarity | NPC474158 |
0.859 | High Similarity | NPC173726 |
0.859 | High Similarity | NPC241600 |
0.8571 | High Similarity | NPC312199 |
0.8562 | High Similarity | NPC471180 |
0.8562 | High Similarity | NPC302610 |
0.8552 | High Similarity | NPC121651 |
0.8544 | High Similarity | NPC469512 |
0.8542 | High Similarity | NPC31530 |
0.8537 | High Similarity | NPC477880 |
0.8537 | High Similarity | NPC477882 |
0.8535 | High Similarity | NPC474770 |
0.8533 | High Similarity | NPC212890 |
0.8533 | High Similarity | NPC87295 |
0.8531 | High Similarity | NPC7744 |
0.8526 | High Similarity | NPC19947 |
0.8526 | High Similarity | NPC207584 |
0.8523 | High Similarity | NPC218841 |
0.8523 | High Similarity | NPC92693 |
0.8521 | High Similarity | NPC237169 |
0.8521 | High Similarity | NPC470624 |
0.8514 | High Similarity | NPC176586 |
0.8514 | High Similarity | NPC210354 |
0.8506 | High Similarity | NPC245948 |
0.85 | High Similarity | NPC88297 |
0.85 | High Similarity | NPC9891 |
0.85 | High Similarity | NPC186845 |
0.8493 | Intermediate Similarity | NPC261714 |
0.8483 | Intermediate Similarity | NPC189474 |
0.8483 | Intermediate Similarity | NPC72796 |
0.8483 | Intermediate Similarity | NPC474139 |
0.8483 | Intermediate Similarity | NPC44245 |
0.8483 | Intermediate Similarity | NPC236522 |
0.8477 | Intermediate Similarity | NPC104024 |
0.8477 | Intermediate Similarity | NPC80230 |
0.8477 | Intermediate Similarity | NPC65574 |
0.8477 | Intermediate Similarity | NPC101755 |
0.8477 | Intermediate Similarity | NPC304687 |
0.8471 | Intermediate Similarity | NPC474043 |
0.8466 | Intermediate Similarity | NPC474568 |
0.8462 | Intermediate Similarity | NPC301897 |
0.8462 | Intermediate Similarity | NPC192255 |
0.8462 | Intermediate Similarity | NPC32373 |
0.8462 | Intermediate Similarity | NPC237946 |
0.8456 | Intermediate Similarity | NPC474288 |
0.8447 | Intermediate Similarity | NPC42230 |
0.8438 | Intermediate Similarity | NPC475953 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC198129 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8506 | High Similarity | NPD37 | Approved |
0.8462 | Intermediate Similarity | NPD4967 | Phase 2 |
0.8462 | Intermediate Similarity | NPD4965 | Approved |
0.8462 | Intermediate Similarity | NPD4966 | Approved |
0.8354 | Intermediate Similarity | NPD6234 | Discontinued |
0.8182 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8143 | Intermediate Similarity | NPD3705 | Approved |
0.8137 | Intermediate Similarity | NPD7199 | Phase 2 |
0.811 | Intermediate Similarity | NPD7228 | Approved |
0.8037 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD7240 | Approved |
0.7785 | Intermediate Similarity | NPD1653 | Approved |
0.7679 | Intermediate Similarity | NPD3818 | Discontinued |
0.7643 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD5494 | Approved |
0.7633 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7619 | Intermediate Similarity | NPD7473 | Discontinued |
0.7597 | Intermediate Similarity | NPD7266 | Discontinued |
0.7584 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7561 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7547 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD6232 | Discontinued |
0.7529 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3817 | Phase 2 |
0.75 | Intermediate Similarity | NPD6674 | Discontinued |
0.7485 | Intermediate Similarity | NPD7074 | Phase 3 |
0.745 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7439 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7439 | Intermediate Similarity | NPD7819 | Suspended |
0.7438 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7427 | Intermediate Similarity | NPD7054 | Approved |
0.7399 | Intermediate Similarity | NPD6559 | Discontinued |
0.7384 | Intermediate Similarity | NPD7472 | Approved |
0.7376 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7371 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD919 | Approved |
0.7355 | Intermediate Similarity | NPD3748 | Approved |
0.7347 | Intermediate Similarity | NPD2981 | Phase 2 |
0.732 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.732 | Intermediate Similarity | NPD1613 | Approved |
0.731 | Intermediate Similarity | NPD5691 | Approved |
0.7308 | Intermediate Similarity | NPD2438 | Suspended |
0.7303 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7297 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7294 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7292 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7289 | Intermediate Similarity | NPD5353 | Approved |
0.7278 | Intermediate Similarity | NPD8127 | Discontinued |
0.7273 | Intermediate Similarity | NPD1934 | Approved |
0.7268 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7257 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7247 | Intermediate Similarity | NPD6841 | Approved |
0.7247 | Intermediate Similarity | NPD6842 | Approved |
0.7247 | Intermediate Similarity | NPD6843 | Phase 3 |
0.7246 | Intermediate Similarity | NPD3882 | Suspended |
0.7235 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7219 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7207 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7202 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7202 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD7685 | Pre-registration |
0.72 | Intermediate Similarity | NPD7251 | Discontinued |
0.7195 | Intermediate Similarity | NPD6055 | Clinical (unspecified phase) |
0.7193 | Intermediate Similarity | NPD5242 | Approved |
0.7171 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD1933 | Approved |
0.7161 | Intermediate Similarity | NPD6355 | Discontinued |
0.716 | Intermediate Similarity | NPD2533 | Approved |
0.716 | Intermediate Similarity | NPD2532 | Approved |
0.716 | Intermediate Similarity | NPD2534 | Approved |
0.7152 | Intermediate Similarity | NPD5762 | Approved |
0.7152 | Intermediate Similarity | NPD5763 | Approved |
0.7151 | Intermediate Similarity | NPD5005 | Approved |
0.7151 | Intermediate Similarity | NPD5006 | Approved |
0.7143 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7126 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7126 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD3750 | Approved |
0.7112 | Intermediate Similarity | NPD7680 | Approved |
0.7101 | Intermediate Similarity | NPD7075 | Discontinued |
0.7099 | Intermediate Similarity | NPD6799 | Approved |
0.7097 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7089 | Intermediate Similarity | NPD2796 | Approved |
0.7081 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7076 | Intermediate Similarity | NPD1247 | Approved |
0.7062 | Intermediate Similarity | NPD7549 | Discontinued |
0.7059 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7052 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7052 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7052 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD6599 | Discontinued |
0.7045 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7027 | Intermediate Similarity | NPD4420 | Approved |
0.7027 | Intermediate Similarity | NPD4626 | Approved |
0.7024 | Intermediate Similarity | NPD2801 | Approved |
0.7019 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7006 | Intermediate Similarity | NPD6386 | Approved |
0.7006 | Intermediate Similarity | NPD6385 | Approved |
0.7006 | Intermediate Similarity | NPD5090 | Approved |
0.7006 | Intermediate Similarity | NPD5089 | Approved |
0.6994 | Remote Similarity | NPD4357 | Discontinued |
0.6982 | Remote Similarity | NPD5402 | Approved |
0.6982 | Remote Similarity | NPD6374 | Clinical (unspecified phase) |
0.6981 | Remote Similarity | NPD3539 | Phase 1 |
0.6975 | Remote Similarity | NPD5084 | Clinical (unspecified phase) |
0.6971 | Remote Similarity | NPD3751 | Discontinued |
0.697 | Remote Similarity | NPD920 | Approved |
0.6968 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD6801 | Discontinued |
0.6962 | Remote Similarity | NPD7097 | Phase 1 |
0.6959 | Remote Similarity | NPD1357 | Approved |
0.6957 | Remote Similarity | NPD1652 | Phase 2 |
0.6957 | Remote Similarity | NPD1243 | Approved |
0.6954 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD1358 | Approved |
0.6948 | Remote Similarity | NPD6832 | Phase 2 |
0.6946 | Remote Similarity | NPD4380 | Phase 2 |
0.6946 | Remote Similarity | NPD7028 | Phase 2 |
0.6943 | Remote Similarity | NPD5124 | Phase 1 |
0.6943 | Remote Similarity | NPD230 | Phase 1 |
0.6943 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD7768 | Phase 2 |
0.694 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.6937 | Remote Similarity | NPD3540 | Phase 1 |
0.6936 | Remote Similarity | NPD3787 | Discontinued |
0.6933 | Remote Similarity | NPD7124 | Phase 2 |
0.6933 | Remote Similarity | NPD1610 | Phase 2 |
0.6933 | Remote Similarity | NPD1611 | Approved |
0.6933 | Remote Similarity | NPD1281 | Approved |
0.6933 | Remote Similarity | NPD422 | Phase 1 |
0.6932 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD6917 | Clinical (unspecified phase) |
0.6927 | Remote Similarity | NPD8313 | Approved |
0.6927 | Remote Similarity | NPD8312 | Approved |
0.6923 | Remote Similarity | NPD4585 | Approved |
0.6923 | Remote Similarity | NPD5563 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD4628 | Phase 3 |
0.6903 | Remote Similarity | NPD4625 | Phase 3 |
0.6886 | Remote Similarity | NPD7458 | Discontinued |
0.6883 | Remote Similarity | NPD2861 | Phase 2 |
0.6879 | Remote Similarity | NPD3134 | Approved |
0.6879 | Remote Similarity | NPD6959 | Discontinued |
0.6875 | Remote Similarity | NPD2935 | Discontinued |
0.6871 | Remote Similarity | NPD6190 | Approved |
0.6867 | Remote Similarity | NPD5403 | Approved |
0.6857 | Remote Similarity | NPD4481 | Phase 3 |
0.6855 | Remote Similarity | NPD6111 | Discontinued |
0.6848 | Remote Similarity | NPD5401 | Approved |
0.6848 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6848 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6846 | Remote Similarity | NPD5585 | Approved |
0.6839 | Remote Similarity | NPD8151 | Discontinued |
0.6839 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD3657 | Discovery |
0.6831 | Remote Similarity | NPD7235 | Clinical (unspecified phase) |
0.6829 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD1091 | Approved |
0.6813 | Remote Similarity | NPD4108 | Discontinued |
0.6813 | Remote Similarity | NPD8434 | Phase 2 |
0.681 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6805 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6805 | Remote Similarity | NPD7411 | Suspended |
0.6802 | Remote Similarity | NPD3749 | Approved |
0.6802 | Remote Similarity | NPD4055 | Discovery |
0.68 | Remote Similarity | NPD17 | Approved |
0.6797 | Remote Similarity | NPD1283 | Approved |
0.6795 | Remote Similarity | NPD7095 | Approved |
0.6788 | Remote Similarity | NPD1511 | Approved |
0.6788 | Remote Similarity | NPD5297 | Approved |
0.6786 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD4005 | Discontinued |
0.6784 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6772 | Remote Similarity | NPD4140 | Approved |
0.6772 | Remote Similarity | NPD3620 | Phase 2 |
0.6772 | Remote Similarity | NPD3619 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD2531 | Phase 2 |
0.677 | Remote Similarity | NPD6099 | Approved |
0.677 | Remote Similarity | NPD6100 | Approved |
0.6765 | Remote Similarity | NPD3384 | Approved |
0.6765 | Remote Similarity | NPD3383 | Approved |
0.6765 | Remote Similarity | NPD3382 | Approved |
0.6757 | Remote Similarity | NPD7296 | Approved |
0.6755 | Remote Similarity | NPD3496 | Discontinued |
0.6753 | Remote Similarity | NPD3267 | Approved |
0.6753 | Remote Similarity | NPD2797 | Approved |
0.6753 | Remote Similarity | NPD3266 | Approved |
0.6752 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6752 | Remote Similarity | NPD5109 | Approved |
0.6752 | Remote Similarity | NPD1296 | Phase 2 |
0.6752 | Remote Similarity | NPD5111 | Phase 2 |
0.6752 | Remote Similarity | NPD6798 | Discontinued |
0.6752 | Remote Similarity | NPD5110 | Phase 2 |
0.6748 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
PubChem CID   | 10099233 |
ChEMBL   | CHEMBL488100 |
ZINC   |
Molecular Weight:   | 556.23 |
ALogP:   | 0.8375 |
MLogP:   | 3.66 |
XLogP:   | 3.634 |
# Rotatable Bonds:   | 18 |
Polar Surface Area:   | 107.98 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 0 |
# Rings:   | 4 |
# Heavy Atoms:   | 40 |